AMSTERDAM, March 19, 2018 -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), both members of the Partners HealthCare...

Newly released artificial intelligence (AI)-driven TissueMark software[1] empowers research labs to enhance quality and reliability, and reduce costs AMSTERDAM and VANCOUVER, British Columbia, March 15, 2018 -- Royal Philips (NYSE: PHG,...

It is that time of year again to celebrate the scientific discoveries and innovations as reviewed by different organizations and publications. Among this year's Popular Science top health innovations of 2017 is Philips' IntelliSite Pathology...

Digital pathology for primary diagnostics is now available. How will it help you improve your clinical workflow and collaboration across sites? Philips is organizing a roadshow across the United States to educate pathologists, lab management...

I recently had an opportunity to speak with Esther Abels, Director of Regulatory, Clinical and Medical Affairs for Philips Digital Pathology Solutions about Philips’ recent approval to market their Philips Intellisite Pathology System (PIPS)...

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA...